Frontage Labs, Inc.
Clinical research clients will benefit from a new strategic partnership between Frontage and DSG Inc., a pioneer of EDC solutions for pharmaceutical and biotech companies. Study coordinators working with Frontage Clinical Services worldwide now have access to DSG’s eCaseLink 8.0 software system.
DSG’s eCaseLink system is a Web based EDC that replaces traditional hand written case report forms (CRFs). Its unique, user friendly eCRFs appear within a browser window and are identical to traditional paper case report forms. This feature is offered only by DSG and simplifies the transition from paper to electronic data collection, saving time and money.
“What study coordinators really like about DSG is that it mirrors the paper CRF,” said Jason Wu, MD, Sr. VP and General Manager of Frontage Clinical Services. “The beauty of DSG is that everybody feels comfortable and confident with it, including the clinical research associates. With the intuitive nature of eCaseLink and the combined expertise of DSG and Frontage, our clinical research customers are getting the right solution and service to make their programs a success,” he added.
While more biopharmaceutical companies have adopted clinical EDC, some remain concerned that technical challenges and start-up costs make the transition risky. The hesitancy comes in part from problems with home grown EDC systems provided by over ambitious contract research organizations. The alliance between Frontage and DSG addresses these concerns with a system that has been validated in more than 1,000 clinical trials and a long history of clinical and technical expertise.
“By employing eCaseLink, Frontage clients will be reducing clinical trial time, improving accuracy, driving down costs, preventing risk, and using data more effectively,” said Al Campbell, VP, Strategic Alliances at DSG. “The most successful clinical trials begin and end with high quality data. With eCaseLink EDC, Frontage customers will have clean data, quick and efficient work flow, accelerated reporting and analysis, rapid database lock, and faster FDA submission and acceptance,” Mr. Campbell said.
Frontage Laboratories, Inc. is a global contract research, development and manufacturing organization, offering a full range of pharmaceutical R&D services. Frontage operates in the US and China, using one seamless GXP platform. Frontage runs three Phase 1 Clinical units, a 72-bed Phase 1 Unit in Hackensack, NJ, a 120-bed Phase 1 Unit in Zhengzhou, Henan Province China, and a-80 bed Phase 1 Unit in Changchun, Jilin Province China. Frontage has an AALAC certified preclinical animal facility in Pennsylvania, where it also maintains bioanalytical and CMC facilities. In Shanghai and Beijing, China, the company also operates bioanalytical and CMC facilities. As a rapidly expanding CRO with ten years of success providing high-quality GXP services, Frontage has established an international standard in pharmaceutical product research, development, quality and management systems.
Since 1992, DSG has been providing results-driven electronic data capture (EDC) and eClinical solutions for clinical trials to some of the top pharmaceutical companies in the world. DSG offers a comprehensive product suite including electronic data capture (EDC), electronic patient diaries (ePRO), data management, robust reporting and data analysis tools. DSG has successfully supported over 1,000 clinical trials for more than 325 companies, at over 18,000 sites in over 68 countries. DSG is a global company headquartered in Malvern, Pa., with additional offices in the U.S., Japan and India.